IndiaTop StoryTop StoryLatest News
Pharmaceuticals Secretary Warns of Malpractice Due to High Margins
Pharmaceuticals Secretary Manoj Joshi expressed concerns about steep margins on medicines leading to unethical practices. The government plans to cap trade margins at 30% on cancer drugs.
Confidence: 90%Sentiment: NeutralHigh Priority
What Happened?
Pharmaceuticals Secretary Manoj Joshi expressed concerns about steep margins on medicines leading to unethical practices. The government plans to cap trade margins at 30% on cancer drugs.
AI Quick Summary
Pharmaceuticals Secretary Manoj Joshi warns that high margins on medicines lead to unethical practices, with the government capping margins on cancer drugs.
Key points
- High margins on medicines can lead to unethical practices.
- Government plans to cap trade margins at 30% for cancer drugs.
- Hospitals may favor expensive medicines with higher margins.
- Smaller manufacturers may create a nexus with doctors through high margins.
- Viability of government-run Jan Aushadhi stores is a challenge due to low margins.
Key insights
- Capping margins may improve access to cancer medications.
- Smaller manufacturers could face challenges in maintaining profitability.
- Hospitals may need to reassess their medication selection practices.
Why it matters
The government's actions could impact the pricing and availability of essential medicines.
Entities
Manoj Joshi· PersonIndia· Country
Source
Times of India
